pdf: Major review of low dose and non-montonic effects for EDCs - Endocrine Reviews

[Guest guest]

fwd:

As some of you may have seen, we just published a huge review of low

dose and non-monotonic effects in Endocrine Reviews, with

Vandenberg as first author. Nothing like it has ever been done.

Birnbaum published an editorial about it in Environmental

Health Perspectives. Marla Cone wrote about it in yesterday's EHN

and included an op-ed by Vandenberg.

Endocrine Reviews chose to make it freely available, even though

their articles are usually by subscription only.

Here are links to the review, the editorial, Cone's story and

Vandenberg's op-ed. I've also pasted in a FAQ sheet we prepared

about the review.

Review: http://bit.ly/A25AWs

Birnbaum's editorial: http://bit.ly/y2RAl0

Cone's story: http://bit.ly/x4bGYO

Vandenberg's op-ed: http://bit.ly/yzjnqK

Don't miss, in the review, an evaluation of how 'weight of the

evidence' risk assessments must be done for EDCs using

endocrinological principles, and what that means for bisphenol A.

Bottom line of the review: Non-monotonicity is common and should be

the default expectation for endocrine disrupting chemicals. This

means a large number of current safety standards are too weak.